163 related articles for article (PubMed ID: 37920431)
1. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
6. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
7. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
[TBL] [Abstract][Full Text] [Related]
8. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
9. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
10. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
Wu X; Chen H; You C; Peng Z
Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
12. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
Wu YP; Lin XD; Chen SH; Ke ZB; Lin F; Chen DN; Xue XY; Wei Y; Zheng QS; Wen YA; Xu N
Front Genet; 2020; 11():892. PubMed ID: 32922436
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
[TBL] [Abstract][Full Text] [Related]
15. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
[TBL] [Abstract][Full Text] [Related]
18. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
Front Genet; 2021; 12():692953. PubMed ID: 34490033
[No Abstract] [Full Text] [Related]
20. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
Wang C; Wang Z; Zhao Y; Jia R
BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
